Cargando…
Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel disease
INTRODUCTION: Patients with inflammatory bowel disease (IBD) suffer from various symptoms, impairing their quality of life and often affecting psychosocial issues. This may lead to the need for additional psychological care. This study investigated patients' subjective need for integrated psych...
Autores principales: | Kutschera, Maximilian, Waldhör, Thomas, Gröchenig, Hans Peter, Haas, Thomas, Wenzl, Heimo, Steiner, Pius, Koch, Robert, Feichtenschlager, Thomas, Eckhardt, Gerald, Mayer, Andreas, Kirchgatterer, Andreas, Ludwiczek, Othmar, Platzer, Reingard, Papay, Pavol, Gartner, Johanna, Fuchssteiner, Harry, Peters, Paul‐Gerhard, Reicht, Gerhard, Moser, Gabriele, Dejaco, Clemens, Vogelsang, Harald, Primas, Christian, Novacek, Gottfried, Miehsler, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259281/ https://www.ncbi.nlm.nih.gov/pubmed/32723070 http://dx.doi.org/10.1177/2050640620946874 |
Ejemplares similares
-
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter Trial
por: Blesl, Andreas, et al.
Publicado: (2023) -
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial
por: Zoller, Heinz, et al.
Publicado: (2023) -
Tofacitinib in the treatment of ulcerative colitis: A position paper issued by the Inflammatory Bowel Disease Working Group of the Austrian Society of Gastroenterology and Hepatology (ÖGGH)
por: Kutschera, Maximilian, et al.
Publicado: (2022) -
First Multicenter Study of Modified Release Phosphatidylcholine “LT-02” in Ulcerative Colitis: A Randomized, Placebo-Controlled Trial in Mesalazine-Refractory Courses
por: Karner, Max, et al.
Publicado: (2014) -
The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients
por: Roth, René, et al.
Publicado: (2021)